We hypothesized that, in NAFLD/NASH, increased expression of miR-650 upregulates both FOXA2 and TEAD2 mRNAs and downregulates LATS2 mRNA. The gene discussed is LATS2; the disease is metabolic dysfunction-associated steatohepatitis.